Access Statistics for James Mason

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Evaluating change in professional behaviour: issues in design and analysis 0 0 0 30 0 0 2 181
NICEly does it: economic analysis within evidence-based clinical practice guidelines 0 0 0 25 0 0 1 148
Optometrist prescribing of therapeutic agents: economic implications for the UK 0 0 1 35 0 0 2 235
Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness 0 0 0 59 0 0 8 400
The DH register of cost-effectiveness studies: a review of study content and quality 0 0 0 28 1 2 7 99
Topical preparations for the treatment of psoriasis in primary care: a systematic review 0 0 0 36 1 2 5 310
Total Working Papers 0 0 1 213 2 4 25 1,373


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines 0 0 0 8 0 0 0 32
Biotechnology: a special case for health technology assessment? 0 0 0 8 0 0 0 35
Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards 0 0 0 0 0 0 0 22
Cost-effectiveness league tables: More harm than good? 0 0 6 52 0 0 11 121
Cost-effectiveness league tables: think of the fans 0 0 2 15 0 0 3 50
Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity 0 0 0 1 0 0 0 19
Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review 0 0 0 0 0 0 3 13
Optometrist prescribing of therapeutic agents: findings of the AESOP survey 0 0 1 12 0 0 1 45
Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’ 0 0 0 0 0 0 0 14
The Importance of Achieving Additional Drug Benefits at a Reasonable Cost 0 0 0 3 0 0 1 66
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 0 0 0 0 0 0 1 3
Total Journal Articles 0 0 9 99 0 0 20 420


Statistics updated 2019-06-03